S. Korea Finds New Talc Problem—Excessive Iron In Japanese Batch
This article was originally published in PharmAsia News
Executive Summary
South Korean authorities say 24 tons of imported Japanese talc have been found to contain excessive amounts of iron. The Korea Testing and Research Institute for Chemical Industry said it measured iron at levels of 0.29 percent, above the 0.25 percent limit set by the Korea FDA. The shipment from Nippon Talc passed through customs April 1, two days before the agency revised iron-content rules along with an order removing asbestos-tainted talc from the market. Japanese talc usually is preferred by larger drug makers because it is believed to have a higher quality than Chinese talc. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.